Cargando…
Two novel missense mutations in the myostatin gene identified in Japanese patients with Duchenne muscular dystrophy
BACKGROUND: Myostatin is a negative regulator of skeletal muscle growth. Truncating mutations in the myostatin gene have been reported to result in gross muscle hypertrophy. Duchenne muscular dystrophy (DMD), the most common lethal muscle wasting disease, is a result of an absence of muscle dystroph...
Autores principales: | Nishiyama, Atsushi, Takeshima, Yasuhiro, Saiki, Kayoko, Narukage, Akiko, Oyazato, Yoshinobu, Yagi, Mariko, Matsuo, Masafumi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855920/ https://www.ncbi.nlm.nih.gov/pubmed/17428346 http://dx.doi.org/10.1186/1471-2350-8-19 |
Ejemplares similares
-
Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients
por: Lee, Tomoko, et al.
Publicado: (2014) -
Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
por: Kemaladewi, Dwi U, et al.
Publicado: (2011) -
Low incidence of limb-girdle muscular dystrophy type 2C revealed by a mutation study in Japanese patients clinically diagnosed with DMD
por: Okizuka, Yo, et al.
Publicado: (2010) -
Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2020) -
Viltolarsen in Japanese Duchenne muscular dystrophy patients: A phase 1/2 study
por: Komaki, Hirofumi, et al.
Publicado: (2020)